231 related articles for article (PubMed ID: 36114538)
1. Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Zhu Y; Zhang JL; Yan XJ; Sun L; Ji Y; Wang FF
Cardiovasc Diabetol; 2022 Sep; 21(1):186. PubMed ID: 36114538
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
Sun T; Huang X; Zhang B; Ma M; Chen Z; Zhao Z; Zhou Y
Front Endocrinol (Lausanne); 2023; 14():1100399. PubMed ID: 36814584
[TBL] [Abstract][Full Text] [Related]
3. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
[TBL] [Abstract][Full Text] [Related]
4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
Liu M; Pan J; Meng K; Wang Y; Sun X; Ma L; Yu X
Sci Rep; 2024 Jan; 14(1):976. PubMed ID: 38200157
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis.
Mao L; Cai D; Chi B; Xiao T; Zou A; Wang Y; Chen Q; Gu Q; Wang Q; Ji Y; Sun L
Eur J Clin Pharmacol; 2023 Jul; 79(7):915-926. PubMed ID: 37099214
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ma X; Sun Y; Cheng Y; Shen H; Gao F; Qi J; Yang L; Wang Z; Shi D; Liu Y; Liu X; Zhou Y
Lipids Health Dis; 2020 Nov; 19(1):240. PubMed ID: 33198752
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of the Triglyceride-Glucose Index in Forecasting Ten-Year Major Adverse Cardiovascular Events in Non-Diabetic Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Köktürk U; Onalan O; Somuncu MU; Uygur B; Erbay İ; Çakan F; Avcı A
Turk Kardiyol Dern Ars; 2024 Jun; 52(4):253-259. PubMed ID: 38829642
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.
Wu Z; Liu L; Wang W; Cui H; Zhang Y; Xu J; Zhang W; Zheng T; Yang J
Cardiovasc Diabetol; 2022 Jul; 21(1):142. PubMed ID: 35906587
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impacts of geriatric nutritional risk index in patients with ischemic heart failure after percutaneous coronary intervention.
Sun T; Ma M; Huang X; Zhang B; Chen Z; Zhao Z; Zhou Y
Clin Nutr; 2023 Aug; 42(8):1260-1267. PubMed ID: 37343410
[TBL] [Abstract][Full Text] [Related]
13. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
[TBL] [Abstract][Full Text] [Related]
14. Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.
Cai D; Chen Q; Mao L; Xiao T; Wang Y; Gu Q; Wang Q; Ji Y; Sun L
Eur J Clin Pharmacol; 2024 Apr; 80(4):613-620. PubMed ID: 38319348
[TBL] [Abstract][Full Text] [Related]
15. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
Gao S; Ma W; Huang S; Lin X; Yu M
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3184-3192. PubMed ID: 34511291
[TBL] [Abstract][Full Text] [Related]
16. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L.
Wang Y; Wang S; Sun S; Li F; Zhao W; Yang H; Wu X
Cardiovasc Diabetol; 2023 Jun; 22(1):150. PubMed ID: 37365588
[TBL] [Abstract][Full Text] [Related]
19. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
